Context Therapeutics Reports First Quarter 2024 Operating and Financial Results

Go back to Context Therapeutics Reports First Quarter 2024 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.20 --0 (-0%)
Previous Close $0.20    52 Week High $ 
Open $0.21    52 Week Low $ 
Day High $0.21    P/E N/A 
Day Low $0.20    EPS $ 
Volume 328,768